During the third quarter, GDS Wealth Management reduced its holding in UnitedHealth Group by 10.7%, selling 5,297 shares and ending the period with 44,252 shares valued at $15.28 million. This follows Cullen Frost Bankers’ 27.1% trim, a sale of 29,527 shares that left the firm with 79,459 shares worth approximately $27.44 million. Meanwhile, several smaller advisors initiated new positions: LFA Lugano Financial Advisors acquired about $25,000 of stock in Q2, Sagard Holdings added $29,000, Grey Fox Wealth Advisors invested $33,000, and Islay Capital Management put in $31,000. Riggs Asset Management increased its stake by 69.4%, purchasing an additional 43 shares to hold 105 shares valued at $33,000. Overall, hedge funds and other institutions now control 87.86% of the company’s outstanding stock.

Analyst sentiment remains constructive: Jefferies raised its target from 317 to 409 and maintains a Buy rating, while Goldman Sachs initiated coverage with a 406 target and Buy recommendation. UBS boosted its target from 378 to 430, Piper Sandler trimmed its target slightly from 423 to 417 but kept an Overweight stance, and Mizuho lifted its target from 300 to 430 with an Outperform rating. Among 29 active analysts, one assigns a Strong Buy, seventeen recommend Buy, nine advise Hold and two rate the stock Sell. The consensus rating is Moderate Buy, with an average target of 386.33.

In its latest quarterly report, UnitedHealth Group delivered earnings per share of 2.92, surpassing expectations by 0.05, and reported revenues of 113.16 billion, roughly flat versus the consensus of 113.19 billion but up 12.2% year-over-year. The company achieved a net margin of 4.04% and a return on equity of 19.23%. Operating segments across both benefits and services contributed to top-line growth, while rising medical costs in Medicare Advantage put modest pressure on margins. The twelve-month trading range sits between 234.60 and 606.36, with a current market capitalization near 323 billion, a price-to-earnings ratio of 18.6 and a PEG ratio of 2.15.

UnitedHealth Group paid a quarterly dividend of 2.21 on December 16, reflecting an annualized payout of 8.84 and a yield of approximately 2.5%. The company’s dividend payout ratio stands at 46.14%, supported by robust free cash flow generation. With a current ratio and quick ratio both at 0.82 and a debt-to-equity ratio of 0.71, the balance sheet provides sufficient liquidity to sustain distributions while funding ongoing investments in technology and care delivery initiatives.